Soreide Law Group is investigating possible investor claims against securities broker Erkan Eric Afacan (CRD: 2563297, Paramus, New Jersey). Evidently, Cambridge Investment Research Inc. permitted Afacan to resign amid allegations of his misconduct. Here is a brief summary of Cambridge Investment Research Inc.’s and investors’ allegations against Afacan.
Afacan worked for Cambridge Investment Research Inc. in Paramus, New Jersey, as a securities broker from January 3, 2007, to October 28, 2022. Supposedly, on September 30, 2022, Cambridge Investment Research Inc. disaffiliated with Afacan. Evidently, Cambridge Investment Research Inc. alleged that Afacan covered account losses in violation of company policy.
Evidently, a client of Cambridge Investment Research Inc. contested Erkan Afacan’s sales practices by filing FINRA Arbitration: 15-01807. Allegedly, Afacan gave unsuitable advice. It appears that Afacan caused the client to sustain damages on BDCs. Therefore, Cambridge Investment Research Inc. opted to settle the matter on November 14, 2016, by compensating the client in the amount of $40,000.
Supposedly, on July 7, 2003, a UBS Financial Services Inc. client filed a complaint about Erkan Afacan. Namely, the client alleged that Afacan made misrepresentations. Because of this, the client allegedly sustained damages on variable annuities. Therefore, the client requested compensation from UBS Financial Services Inc. or Afacan. However, the securities firm denied this complaint.
Suffer damages because of Erkan Afacan? If so, reach out to Soreide Law Group at (888) 760-6552 and talk with a securities attorney about a possible recovery of your losses. Soreide Law Group, who has effectively recovered money for investors throughout the United States, represents investors on a contingency fee basis and advances costs. Afacan and brokerage firms Afacan worked for deny accusations against them.
Investors apparently complained about securities broker Debra Dawn Mesle (also known as Debra Dawn Hanebrink and Debbie Mesle) [CRD: 849766, Chesterfield, Missouri], based on public information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Mesle worked for Merrill Lynch from June 30, 2006, to January 2, 2026, and has worked for Huntleigh Securities Corporation and Huntleigh […]
Investors potentially experienced sales practice violations by securities broker Francis Stephen Zoracki, also known as Frank Zoracki [CRD: 1363103, Irwin, Pennsylvania], according to information disclosed through Financial Industry Regulatory Authority (FINRA) BrokerCheck. Zoracki has worked for Cambridge Investment Research Inc. since September 28, 2011; Cambridge Investment Research Advisors Inc. since September 28, 2011; and Duncan […]
Investors may have suffered financial harm by securities broker and investment adviser Loren James Grabau [CRD: 6984490, Santa Maria, California], given the public information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Grabau worked for Independent Financial Group LLC from April 8, 2019, to August 19, 2025. See below to discover more about Grabau’s disclosures. […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com